These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26391425)

  • 1. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tardive dyskinesia in a child treated with atypical antipsychotics].
    Wittevrongel E; Vranken E; Pepermans A; Jaspers T
    Tijdschr Psychiatr; 2020; 62(10):901-905. PubMed ID: 33184822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert dyskinesia associated with aripiprazole: a case report and review of the literature.
    Moseley CN; Simpson-Khanna HA; Catalano G; Catalano MC
    Clin Neuropharmacol; 2013; 36(4):128-30. PubMed ID: 23860346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins.
    She S; Kuang Q; Zheng Y
    Schizophr Res; 2018 Jul; 197():564-565. PubMed ID: 29128325
    [No Abstract]   [Full Text] [Related]  

  • 5. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
    Selfani K; Soland VL; Chouinard S; Huot P
    Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
    Macaluso M; Flynn A; Preskorn S
    J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
    Preskorn S; Flynn A; Macaluso M
    J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covert Dyskinesia With Aripiprazole: A Case Report.
    Mahgoub Y; Hameed A; Francis A
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722028
    [No Abstract]   [Full Text] [Related]  

  • 13. Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.
    Gomaa H; Mahgoub Y; Francis A
    J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):67-70. PubMed ID: 33347026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
    Miller DD; Eudicone JM; Pikalov A; Kim E
    J Clin Psychiatry; 2007 Dec; 68(12):1901-6. PubMed ID: 18162021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
    Joe S; Park J; Lim J; Park C; Ahn J
    BMC Psychiatry; 2015 Oct; 15():253. PubMed ID: 26482558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
    Chan CH; Chan HY; Chen YC
    Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A; Lajeunesse C
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole-induced improvement in tardive dyskinesia.
    Duggal HS
    Can J Psychiatry; 2003 Dec; 48(11):771-2. PubMed ID: 14733461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.